Immune response to Streptomyces lividans in mice: A potential vaccine vehicle against TB

Open Vaccine Journal

Volumn 2, Issue , 2009, Pages 85-91

  Vallin, Carlos ^a   Ayala, Julio C ^a   García Rivera, Dagmar ^b   Jones, Jony ^c   Rodríguez, Caridad ^a   González, Leonora ^a   Hernández, Ivones ^b   Pimienta, Elsa ^a   Vila, Ailin ^d   Sarmiento, María E ^d   Acosta, Armando ^d   Anné, Jozef ^e   Van Mellaert, Lieve ^e  

^a UNIVERSITY OF HAVANA   (Cuba)

^b Center of Biomolecular Chemistry   (Cuba)

^c Hospital Universitario Comandante Manuel Fajardo   (Cuba)

^d FINLAY INSTITUTE   (Cuba)

^e REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Immune response; Live vaccine; Mycobacterium tuberculosis; Streptomyces lividans; Tuberculosis strategies

Indexed keywords

BCG VACCINE; CROSS REACTING ANTIBODY; GAMMA INTERFERON; LIVE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; BCG VACCINATION; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; MOUSE; MYCELIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SPLEEN CELL; STREPTOMYCES LIVIDANS; TUBERCULOSIS;

EID: 77953369373     PISSN: None     EISSN: 18750354     Source Type: Journal    
DOI: 10.2174/1875035400902010085     Document Type: Article

References (35)

1. Kochi, A. The global tuberculosis situation and the new control strategy of the World Health Organization. Bull. World Health Organ., 2001, 79, 71-75.
2. Canetti, G.; Sutherland, I.; Svandova, E. Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis: Bull. Int. Union Tuberc., 1972, 47, 116-134.
3. Corbett, E.L.; Watt, C.J.; Walker, N.; Maher, D.; Williams, B.G.; Raviglione, M.C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med., 2003, 163, 1009-1021.
4. Blanco, A. Nuevas vacunas contra la tuberculosis obtenidas a partir de los avances inmunitarios y genéticos. Bol. Pediatr., 2006, 46, 7-22.
5. Skeiky, Y.A.; Sadoff, J.C. Advances in tuberculosis vaccine strategies. Nat. Rev. Microbiol., 2006, 4, 469-476.
6. Orme, I.M. Preclinical testing of new vaccines for tuberculosis: A comprehensive review. Vaccine, 2006, 24, 2-19.
7. Williams, A.; Hatch, G.J.; Clark, S.O. Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis, 2005, 85, 29-38.
8. Paterson, R. Human trials start for new tuberculosis vaccine. Lancet Infect. Dis., 2001, 1 (5), 291.
9. Kieser, T.; Bibb, M.; Buttner, M.; Chater, K.; Hopwood, D. Practical Streptomyces Genetics. The John Innes Foundation: Norwich, England, 2000.
10. Embley, T.M.; Stackebrandt, E. The molecular phylogeny and systematic of the actinomycetes. Annu. Rev. Microbiol., 1994, 48, 257-289.
11. Goodfellow, M. Bergey's Manual of Systematic Bacteriology: In Suprageneric Classification of Actinomycetes, Williams, S.T., Ed.; Baltimore, 1989, Vol. 4, pp. 2333-2339.
12. Hong, B.; Wu B, Li Y. Production of C-terminal amidated recombinant salmon calcitonin in Streptomyces lividans. Appl. Biochem. Biotechnol., 2003, 110, 113-123. (Pubitemid 37159416)
13. Lara, M.; Servin-Gonzalez, L.; Singh, M.; Moreno, C.; Cohen, I.; Nimtz, M.; Espitia, C. Expression, secretion, and glycosylation of the 45- and 47-kDa glycoprotein of Mycobacterium tuberculosis in Streptomyces lividans. Appl. Environ. Microbiol., 2004, 70, 679-685.
14. Sianidis, G.; Pozidis, C.; Becker, F.; Vrancken, K.; Sjoeholm, C.; Karamanou, S. Takamiya-Wik, M.; Van Mellaert, L.; Schaefer, T.; Anné, J.; Economou, A. Functional large-scale production of a novel Jonesia sp. xyloglucanase by heterologous secretion from Streptomyces lividans. J. Biotechnol., 2006, 121, 498-507. (Pubitemid 43201928)
15. Tremblay, D.; Lemay, J.; Gilbert, M.; Chapdelaine, Y.; Dupont, C.; Morosoli, R. High-level heterologous expression and secretion in Streptomyces lividans of two major antigenic proteins from Mycobacterium tuberculosis. Can. J. Microbiol., 2002, 48 (1), 43-48. (Pubitemid 34258649)
16. Orekhov, A.V.; Strokina, I.V.; Furs, A.R. Restriction of two-replicon shuttle Escherichia coli-Streptomyces plasmids in Streptomyces lividans strain 66. Genetika, 1989, 25, 614-625.
17. Engels, J.W.; Koller K-P.; In Gene expression and secretion of eukaryotic foreign proteins in Streptomyces; Murray, J.A.H., Ed.; John Wiley and Sons: New York, 1992, pp. 32-53.
18. Vallin, C.; Ramos, A.; Pimienta, E.; Rodríguez, C.; Hernández, T.; Hernández, I.; Del Sol, R.; Rosabal, G.; Van Mellaert, L.; Anne, J. Streptomyces as host for recombinant production of Mycobacterium tuberculosis proteins. Tuberculosis, 2006, 86, 198-202.
19. Anné, J.; Van Mellaert, L.; Eyssen, H. Optimum conditions for efficient transformation of Streptomyces venezuelae protoplasts. Appl. Microbiol. Biotechnol., 1990, 32, 431-435. (Pubitemid 20095296)
20. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem., 1976, 72, 248-254.
21. Andersen, P.; Askgaard, D.; Ljungqvist, L.; Bennedsen, J.; Heron, I. Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun., 1991, 59, 1905-1910.
22. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65 (1-2), 55-63. (Pubitemid 14203433)
23. Young, D.B. Building a better tuberculosis vaccine. Nat. Med., 2003, 9, 503-504.
24. Díaz, M.; Esteban, A.; Fernández-Abalos, J.M.; Santamaría, R.I. The high-affinity phosphate-binding protein PstS is accumulated under high fructose concentrations and mutation of the corresponding gene affects differentiation in Streptomyces lividans. Microbiology, 2005, 151, 2583-2592.
25. Chang, Z.; Choudhary, A.; Lathigra, R.; Quiocho, F.A. The immunodominant 38-kDA lipoprotein antigen of Mycobacterium tuberculosis is a phosphate-binding protein. J. Biol. Chem., 1994, 269, 1956-1958. (Pubitemid 24035399)
26. Sarmiento, M.E.; Acosta, A.; Vallin, C.; Olivares, N.; López, Y.; Rodríguez, C.; Martinez, M.; Gonzalez, L.; Infante, J.F.; Ramos, A. Vaccine compositions which are obtained from Streptomyces. Patent/WO/2005/ 087259, September 29, 2005. (Available at: http://www.freepatentsonline.com/ EP1743651.html)
27. Bentley, S.D.; Chater, K.F.; Cerdeño-Tárraga, A.M.; Challis, G.L.; Thomson, N.R.; James, K.D.; Harris, D.E.; Quail, M.A.; Kieser, H.; Harper, D.; Bateman, A.; Brown, S.; Chandra, G.; Chen, C.W.; Collins, M.; Cronin, A.; Fraser, A.; Goble, A.; Hidalgo, J.; Hornsby, T.; Howarth, S.; Huang, C.H.; Kieser, T.; Larke, L.; Murphy, L.; Oliver, K.; O'Neil, S.; Rabbinowitsch, E.; Rajandream, M.A.; Rutherford, K.; Rutter, S.; Seeger, K.; Saunders, D.; Sharp, S.; Squares, R.; Squares, S.; Taylor, K.; Warren, T.; Wietzorrek, A.; Woodward, J.; Barrell, B.G.; Parkhill, J.; Hopwood, D.A. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature, 2002, 417, 141-147. (Pubitemid 34506788)
28. Roupie, V.; Romano, M.; Zhang, L.; Korf1, H.; Lin, M.Y.; Franken, K.; Ottenhoff, T.; Klein, M.R.; Huygen, K. Immunogenicity of eight dormancy (DosR) regulon encoded proteins of Mycobacterium tuberculosis in DNA vaccinated and TB infected mice. Infect. Immun., 2007, 75, 941-949. (Pubitemid 46203459)
29. Armstrong, J.A.; Hart, P.D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med., 1971, 134, 713-740
30. Armstrong, J.A.; Hart, P.D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med., 1975, 142, 1-16.
31. Chan, X.; Xing, Y.; Magliozzo, R.S.; Bloom, B.R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated macrophages. J. Exp. Med., 1992, 175, 1111-1122
32. Scanga, C.A.; Mohan, V.P.; Yu, K.; Joseph, H.; Tanaka, K.; Chan, J.; Flynn, J.L. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J. Exp. Med., 2000, 192 (3), 347-358.
33. Serbina, N.V.; Lazarevic, V.; Flynn, J.L. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J. Immunol., 2001, 167, 6991-7000.
34. Oddo, M.; Renno, T.; Attinger, A.; Bakker, T.; MacDonald, H.R.; Meylan, P.R. Fas ligandinduced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol., 1998, 160, 5448-5454
35. Brosch, R.; Gordon, S.V.; Garnier, T.; Eiglmeier, K.; Frigui, W.; Valenti, P.; Dos Santos, S.; Duthoy, S.; Lacroix, C.; Garcia-Pelayo, C.; Inwald, J.K.; Golby, P.; Garcia, J.N.; Hewinson, R.G.; Behr, M.A.; Quail, M.A.; Churcher, C.; Barrell, B.G.; Parkhill, J.; Cole, S.T. Genome plasticity of BCG and impact on vaccine efficacy. Proc. Natl. Acad. Sci., USA, 2007, 104, 5596-5601.